Cart summary

You have no items in your shopping cart.

Dihydrotanshinone I

SKU: orb1304266

Description

Dihydrotanshinone I

Research Area

Immunology & Inflammation, Infectious Disease & Virology

Images & Validation

Key Properties

CAS Number87205-99-0
MW278.30
Purity99.59%
FormulaC18H14O3
SMILESCC1COC2=C1C(=O)C(=O)c1c2ccc2c(C)cccc12
TargetROS,SARS-CoV
SolubilityDMSO:3.85 mg/mL (13.83 mM)

Bioactivity

In Vivo
In ApoE-/- mice fed with an atherogenic diet, DHT (10 and 25 mg kg-1) significantly attenuated atherosclerotic plaque formation, altered serum lipid profile, decreased oxidative stress and shrunk necrotic core areas. DHT dramatically inhibits the enhanced expression of LOX-1, NOX4, and NF-κB in aorta. Dihydrotanshinone I (1, 2, 4 mg/kg) treatment can improve cardiac function, reduce infarct size, ameliorate the variations in myocardial zymogram and histopathological disorders, decrease 20-HETE generation, and regulate apoptosis-related protein in myocardial ischemia-reperfusion rats.
In Vitro
Dihydrotestosterone (DHT, 10 nM) effectively reduces the expression of lectin-like ox-LDL receptor-1 (LOX-1) and NADPH oxidase 4 (NOX4), alongside diminishing reactive oxygen species (ROS) production, nuclear translocation of NF-κB, ox-LDL endocytosis, and monocyte adhesion in lipopolysaccharide (LPS)-stimulated human umbilical vein endothelial cells (HUVECs). Additionally, Dihydrotanshinone I prompts caspase-dependent apoptosis in HCT116 cells, with this apoptosis being both concentration and ROS dependent. The presence of Z-VAD-fmk entirely prevents apoptosis, while pre-treatment with Z-LEHD-fmk significantly reduces it, and Z-IETD-fmk only achieves partial inhibition. Intriguingly, knocking down caspase-2 significantly enhances apoptosis induced by Dihydrotanshinone I.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Dihydrotanshinone I, DHTS, 15,16-dihydrotanshinone I, inhibit, Inhibitor, ROS, SARSCoV, SARS coronavirus, SARS-CoV

Similar Products

  • Dihydrotanshinone I (Standard) [orb3139798]

    87205-99-0

    278.30

    C18H14O3

    10 mg
  • Dihydrotanshinone I [orb1223788]

    >98%(HPLC)

    87205-99-0

    278.3

    C18H14O3

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Dihydrotanshinone I (orb1304266)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

2 mg
$ 80.00
5 mg
$ 100.00
10 mg
$ 140.00
25 mg
$ 240.00
50 mg
$ 320.00
100 mg
$ 500.00
200 mg
$ 680.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry